ACAD
48.6
-0.7
-1.42%
AEMD
9.55
-0.03
-0.31%
APRI
1.49
+0.02
+1.36%
ARNA
4.09
+0.01
+0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.93
-0.09
-1.79%
CRXM
0.3
0.00
0.00%
CYTX
0.44
0.00
0.00%
DXCM
83.56
+0.15
+0.18%
GNMK
8.75
-0.08
-0.91%
HALO
23.43
-0.28
-1.18%
ILMN
217.19
-0.63
-0.29%
INNV
0.155
0.00
0.00%
INO
7.4
0.00
0.00%
ISCO
0.043
0.00
0.00%
ISIS
53.05
-1.35
-2.48%
LGND
106.86
+1.02
+0.96%
LPTN
0.275
-0.005
-1.8571%
MBVX
1.8
+0.21
+13.21%
MEIP
1.65
+0.08
+5.10%
MNOV
3.87
+0.22
+6.03%
MRTX
27.46
-1.84
-6.28%
MSTX
0.454
-0.006
-1.2609%
NBIX
50.66
-1.26
-2.43%
NUVA
54.59
+4.12
+8.16%
ONCS
6.17
-0.1
-1.59%
ONVO
3.54
+0.17
+5.04%
OREX
3.91
-0.48
-10.93%
OTIC
26.11
-1.17
-4.29%
QDEL
21.47
-0.41
-1.87%
RCPT
227.64
+0.48
+0.21%
RGLS
8.19
-0.73
-8.18%
RMD
55.92
-0.78
-1.38%
SCIE
0.02
0.00
0.00%
SPHS
0.9
-0.01
-1.1425%
SRNE
19.2
-1.21
-5.93%
TROV
8.01
-0.34
-4.07%
VICL
0.638
-0.002
-0.2656%
ZGNX
18.49
-1.65
-8.19%
ACAD
48.6
-0.7
-1.42%
AEMD
9.55
-0.03
-0.31%
APRI
1.49
+0.02
+1.36%
ARNA
4.09
+0.01
+0.25%
ATEC
1.36
0.00
0.00%
CNAT
4.93
-0.09
-1.79%
CRXM
0.3
0.00
0.00%
CYTX
0.44
0.00
0.00%
DXCM
83.56
+0.15
+0.18%
GNMK
8.75
-0.08
-0.91%
HALO
23.43
-0.28
-1.18%
ILMN
217.19
-0.63
-0.29%
INNV
0.155
0.00
0.00%
INO
7.4
0.00
0.00%
ISCO
0.043
0.00
0.00%
ISIS
53.05
-1.35
-2.48%
LGND
106.86
+1.02
+0.96%
LPTN
0.275
-0.005
-1.8571%
MBVX
1.8
+0.21
+13.21%
MEIP
1.65
+0.08
+5.10%
MNOV
3.87
+0.22
+6.03%
MRTX
27.46
-1.84
-6.28%
MSTX
0.454
-0.006
-1.2609%
NBIX
50.66
-1.26
-2.43%
NUVA
54.59
+4.12
+8.16%
ONCS
6.17
-0.1
-1.59%
ONVO
3.54
+0.17
+5.04%
OREX
3.91
-0.48
-10.93%
OTIC
26.11
-1.17
-4.29%
QDEL
21.47
-0.41
-1.87%
RCPT
227.64
+0.48
+0.21%
RGLS
8.19
-0.73
-8.18%
RMD
55.92
-0.78
-1.38%
SCIE
0.02
0.00
0.00%
SPHS
0.9
-0.01
-1.1425%
SRNE
19.2
-1.21
-5.93%
TROV
8.01
-0.34
-4.07%
VICL
0.638
-0.002
-0.2656%
ZGNX
18.49
-1.65
-8.19%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …